MedTrace Logo

Oral Glucose Intervention for Children With Gastroenteritis and Ketosis

NCT02729870 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-01-29

No results posted yet for this study

Summary

Fasting ketoacidosis adds morbidity to children affected by gastrointestinal infections. The investigators investigate oral glucose gel for its effectiveness in rapidly reducing ketoacidosis and for improvements in oral hydration therapy success.

Conditions

  • Gastrointestinal Infections
  • Ketosis

Interventions

DRUG

Oral Glucose Gel

This group will receive the following: are less than 3 year of age will receive 7.5 gram oral glucose gel 40% (0.66 oz, 20ml) which will be a one time dose and the subjects who are ages 3-7 will receive 15 gram oral glucose gel (1.3 oz, 40ml) which is a one time dose.

OTHER

Placebo

This group will receive carboxymethylcellulose (2%) oral gel. The subjects who are less than than 3 years of age will receive carboxymethylcellulose (2%) oral gel, 20ml which will be a one time dose and the subjects ages 3-7 will receive carboxymethylcellulose (2%) oral gel, 40ml which will be a one time dose.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Fred R Guyer, MD · University of Florida Assisstant Professor

Eligibility

Min Age
1 Year
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02729870 on ClinicalTrials.gov